BPC-157 stands for Body Protection Compound-157, a peptide fragment derived from a naturally occurring protein in the stomach
&srotate=0)
Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018

The clinical evidence base is more developed than for many compounded peptides, and it is also more honestly mixed than the marketing typically suggests
Swelling, redness, or irritation of injection site
Getting your B12 injections has never been easier or more comfortable
This personalized approach ensures optimized energy, mental performance, and immune support for the most effective and balanced wellness results